Ensysce Biosciences Inc
ENSC2.135USD
+0.085+4.15%
交易中 （美東）報價延遲15分鐘
3.51M總市值
虧損本益比TTM
關於 Ensysce Biosciences Inc 公司
Ensysce Biosciences, Inc. 是一家臨牀階段製藥公司。該公司開發用於緩解嚴重疼痛的解決方案，同時降低阿片類藥物誤用、濫用和過量服用的可能性。其產品線包括兩個新藥平臺：一種抗濫用阿片類藥物前藥技術，即胰蛋白酶激活濫用保護 (TAAP) 平臺，以及一種過量服用保護阿片類藥物前藥技術，即多藥片濫用保護 (MPAR) 平臺。TAAP 平臺旨在改善對慢性疼痛患者的護理，同時降低與處方阿片類藥物濫用相關的人力和經濟成本。MPAR 平臺與其 TAAP 前藥結合使用，旨在防止處方藥濫用，同時也減少過量服用的發生。此外，作爲其過量服用保護組合產品的一種成分，萘莫司他二甲磺酸鹽 (nafamostat) 也正在開發中，用於治療感染和肺部疾病。
公司簡介
公司代碼ENSC
公司名稱Ensysce Biosciences Inc
上市日期Dec 01, 2017
CEODr. Lynn D. Kirkpatrick, Ph.D.
員工數量7
證券類型Ordinary Share
年結日Dec 01
公司地址7946 Ivanhoe Avenue, Suite 201
城市LA JOLLA
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編92037
電話18582634196
網址https://ensysce.com/
公司代碼ENSC
上市日期Dec 01, 2017
CEODr. Lynn D. Kirkpatrick, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. David Carl Humphrey, CPA
Mr. David Carl Humphrey, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
10.00
--
Dr. Linda Pestano, Ph.D.
Dr. Linda Pestano, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Mr. William H.C. Chang
Mr. William H.C. Chang
Independent Director
Independent Director
--
--
Ms. Lee M. Rauch
Ms. Lee M. Rauch
Independent Director
Independent Director
--
--
Mr. Geoffrey Birkett
Mr. Geoffrey Birkett
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Lynn D. Kirkpatrick, Ph.D.
Dr. Lynn D. Kirkpatrick, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steve R. Martin
Mr. Steve R. Martin
Independent Director
Independent Director
--
--
Bob G. Gower ,
Bob G. Gower ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Jeffrey Millard, Ph.D.
Dr. Jeffrey Millard, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Curtis Rosebraugh, M.D.
Dr. Curtis Rosebraugh, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David Carl Humphrey, CPA
Mr. David Carl Humphrey, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
10.00
--
Dr. Linda Pestano, Ph.D.
Dr. Linda Pestano, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Mr. William H.C. Chang
Mr. William H.C. Chang
Independent Director
Independent Director
--
--
Ms. Lee M. Rauch
Ms. Lee M. Rauch
Independent Director
Independent Director
--
--
Mr. Geoffrey Birkett
Mr. Geoffrey Birkett
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Lynn D. Kirkpatrick, Ph.D.
Dr. Lynn D. Kirkpatrick, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月9日 週三
更新時間: 7月9日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Murchinson Ltd.
5.91%
Perceptive Advisors LLC
3.66%
Adage Capital Management, L.P.
3.15%
Sabby Management, LLC
1.98%
Gower (Robert G)
0.34%
Other
84.96%
持股股東
持股股東
佔比
Murchinson Ltd.
5.91%
Perceptive Advisors LLC
3.66%
Adage Capital Management, L.P.
3.15%
Sabby Management, LLC
1.98%
Gower (Robert G)
0.34%
Other
84.96%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
8.01%
Private Equity
3.66%
Hedge Fund
3.17%
Individual Investor
0.43%
Investment Advisor
0.07%
Other
84.65%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
36
363.87K
15.35%
+63.12K
2025Q1
36
363.47K
15.33%
+62.49K
2024Q4
41
152.48K
11.69%
-180.25K
2024Q3
42
173.09K
26.96%
+116.42K
2024Q2
41
44.94K
12.13%
-919.00
2024Q1
43
31.95K
18.34%
-413.00
2023Q4
44
15.51K
10.50%
-18.28K
2023Q3
49
27.39K
26.75%
-10.01K
2023Q2
49
42.64K
49.41%
+30.89K
2023Q1
50
17.95K
33.35%
+9.03K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Murchinson Ltd.
140.00K
5.91%
+140.00K
--
Mar 31, 2025
Perceptive Advisors LLC
86.67K
3.66%
--
--
Mar 31, 2025
Adage Capital Management, L.P.
74.71K
3.15%
+24.71K
+49.42%
Mar 31, 2025
Sabby Management, LLC
46.95K
1.98%
+46.95K
--
Mar 31, 2025
Gower (Robert G)
8.13K
0.34%
--
--
Mar 07, 2025
FNY Investment Advisers LLC
3.00K
0.13%
--
--
Mar 31, 2025
Benton (Andrew K. J.D.)
1.33K
0.06%
--
--
Mar 07, 2025
UBS Financial Services, Inc.
1.31K
0.06%
+713.00
+119.83%
Mar 31, 2025
Chang (William H C)
722.00
0.03%
-1.33K
-64.85%
Mar 07, 2025
Tower Research Capital LLC
441.00
0.02%
+3.00
+0.68%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
公告日期
類型
比率
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
Oct 27, 2022
Merger
20<1
Oct 27, 2022
Merger
20<1
查看更多
